Foley Partner Andrew Rawlins was quoted in an article titled “BMS Sells ConvaTec: Are More Private Equity Deals on the Way?” in the May issue of MX Magazine. Rawlins gave his insight into private equity deals in the medtech industry. The article examined the recent trend of private equity firms acquiring large medtech companies valued at $500 million and greater and noted an expected slowdown in such deals as the current credit squeeze begins to affect the medtech industry.
People
Related News
08 November 2024
In the News
Federico Goudie on Brazil as Key Market – 'It just happens that Miami is a smart place to be'
Foley & Lardner LLP partner Federico Goudie shared insight on the growing importance of Brazil to the U.S. legal market in Daily Business Review, identifying Miami as a key place to be for firms working with Brazilian clients and Latin American clients more broadly.
08 November 2024
In the News
Louis Lehot Assesses 2024 Election Result, Prospect of Tech Deal Resurgence
Foley & Lardner LLP partner Louis Lehot appeared across legal and business press to discuss the likelihood of a resurgence across capital markets, venture capital, and tech M&A following the results of the 2024 U.S. presidential election.
07 November 2024
In the News
James McKee on Amendment 3's Failed Passage – 'Florida still has a significant market'
Foley & Lardner LLP partner James McKee's assessment of the future of the cannabis industry in Florida following the failed passage of Amendment 3, a constitutional amendment that would have legalized recreational use of marijuana for adults, appeared across media outlets, including CBS News Miami, NBC 6 South Florida, NPR/WUSF, Orlando Sentinel, South Florida Sun Sentinel, and WMNF 88.5 FM.